NEUWAY Pharma Competitors and Similar CompaniesClear all
NEUWAY Pharma's competitors and similar companies include BioCryst Pharmaceuticals, Fortress Biotech, Boston Analytical and Bioiberica.
 NEUWAY Pharma NEUWAY Pharma is a company that focuses on the preclinical and clinical development of therapeutics for the treatment of severe orphan brain diseases. |  BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Fortress Biotech Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. |  Boston Analytical Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing. |  Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | |
Founding Date | Founding Date 2014 | Founding Date 1986 | Founding Date 2006 | Founding Date 1987 | Founding Date 1975 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Bonn, DE HQ | Locations Durham, US HQ Hoover, US | Locations New York, US HQ Waltham, US | Locations Salem, US HQ | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES |
Employees | Employees 1225% decrease | Employees 14040% increase | Employees 10146% decrease | Employees 2441% decrease | Employees 332 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) 55.7 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) $63.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $346.7m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods $20.9m (FY, 2025) | Cost of goods N/A | Cost of goods $190.3m (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit $42.3m (FY, 2025) | Gross profit N/A | Gross profit $156.4m (FY, 2018) |
Net income | Net income N/A | Net income $263.9m (FY, 2025) | Net income ($32.9m) (FY, 2025) | Net income N/A | Net income $40.5m (FY, 2018) |
For sources of this data, please see the company profile
View Company Profiles
BioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyFortress Biotech
HQ
New York, US
Employees
101↓ 46% decrease
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
View companyBoston Analytical
HQ
Salem, US
Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing.
View companyBioiberica
HQ
Esplugues de Llobregat, ES
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View company